scholarly journals A randomised clinical trial of comprehensive cardiac rehabilitation versus usual care for patients treated for infective endocarditis—the CopenHeartIEtrial protocol

BMJ Open ◽  
2012 ◽  
Vol 2 (6) ◽  
pp. e001929 ◽  
Author(s):  
Trine Bernholdt Rasmussen ◽  
Ann-Dorthe Zwisler ◽  
Kirstine Lærum Sibilitz ◽  
Signe Stelling Risom ◽  
Henning Bundgaard ◽  
...  
Trials ◽  
2013 ◽  
Vol 14 (1) ◽  
pp. 104 ◽  
Author(s):  
Kirstine Laerum Sibilitz ◽  
Selina Kikkenborg Berg ◽  
Tina Birgitte Hansen ◽  
Signe Stelling Risom ◽  
Trine Bernholdt Rasmussen ◽  
...  

Heart ◽  
2016 ◽  
Vol 102 (24) ◽  
pp. 1995-2003 ◽  
Author(s):  
Kirstine L Sibilitz ◽  
Selina K Berg ◽  
Trine B Rasmussen ◽  
Signe Stelling Risom ◽  
Lau C Thygesen ◽  
...  

2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
E.P. Meindersma ◽  
J.A. Snoek ◽  
L.F. Prins ◽  
M.J. De Boer ◽  
M.T. Hopman ◽  
...  

Author(s):  
Maria Giné-Garriga ◽  
Philippa M. Dall ◽  
Marlene Sandlund ◽  
Javier Jerez-Roig ◽  
Sebastien F. M. Chastin ◽  
...  

Care-home residents are among the most sedentary and least active of the population. We aimed to assess the feasibility, acceptability, safety, and preliminary effects of an intervention to reduce sedentary behaviour (SB) co-created with care home residents, staff, family members, and policymakers within a pilot two-armed pragmatic cluster randomized clinical trial (RCT). Four care homes from two European countries participated, and were randomly assigned to control (usual care, CG) or the Get Ready intervention (GR), delivered by a staff champion one-to-one with the care home resident and a family member. A total of thirty-one residents participated (51.6% female, 82.9 (13.6) years old). GR involves six face to face sessions over a 12-week period with goal-oriented prompts for movement throughout. The feasibility and acceptability of the intervention were assessed and adverse events (AEs) were collected. The preliminary effects of the GR on SB, quality of life, fear of falling, and physical function were assessed. Means and standard deviations are presented, with the mean change from baseline to post-intervention calculated along with 95% confidence intervals. The CG smoked more, sat more, and had more functional movement difficulties than the GR at baseline. The GR intervention was feasible and acceptable to residents and staff. No AEs occurred during the intervention. GR participants showed a decrease in daily hours spent sitting/lying (Cohen’s d = 0.36) and an increase in daily hours stepping, and improvements in health-related quality of life, fear of falling, and habitual gait speed compared to usual care, but these effects need confirmation in a definitive RCT. The co-created GR was shown to be feasible and acceptable, with no AEs.


2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
Y Wu ◽  
X Yu ◽  
Y Zhu ◽  
C Shi ◽  
X Li ◽  
...  

Abstract Background Depression and acute coronary syndromes (ACS) are significant public health challenges. Patients with ACS often experience depression, which adversely affects prognosis. Low-cost, sustainable, and effective service models that integrate depression care into the management of ACS patients to reduce depression and improve ACS outcomes are critically needed. Purpose I-CARE study is a multi-center, randomised clinical trial (RCT) to evaluate the efficacy of an 11-month integrated care (IC) intervention compared to usual care (UC) in the management of ACS patients. Methods The I-CARE RCT was conducted between October 2014 and March 2018 in 16 rural Chinese hospitals. A total of 4041 patients with ACS were consecutively enrolled and randomly assigned in a 1:1 ratio to an IC intervention consisting of nurse-led risk factor management, group-based counseling supplemented by individual problem solving therapy and antidepressant medications as needed, or UC. The primary outcome was change in Patient Health Questionnaire-9 (PHQ-9) scores from baseline to 6 and 12 months. Secondary outcomes included incidence of major adverse events (MAEs) after discharge, quality of life (EQ5D), and adherence to ACS secondary prevention medications. Data analysis used a multilevel mixed-effects model with hospital-level and subject-level random-effect intercepts and hospital-level random slope incorporated to adjust for clustering effect. Primary analyses followed the intent-to-treat principle. Results The mean age of the patients was 61±10 years and 63% were men; however, only 3.3% were classified as depressed based upon a cutoff of ≥10 on the PHQ-9, and 26.9% had PHQ-9 scores between 5 to 9 at the baseline. There were no significant differences in patients' clinical characteristics between IC and UC groups. Changes in PHQ-9 scores from baseline to 6- and 12-months did not differ between treatment groups (−1.47 in IC group vs −1.40 in UC group; adjusted mean difference, −0.04; 95% CI, −0.17 to 0.08 at 6-months; −1.62 in IC group vs −1.54 in UC group; adjusted mean difference, −0.06; 95% CI: −0.19 to 0.06 at 12-months).The risk of MAEs after discharge between IC and UC groups also did not differ significantly (42.1% vs 43.1%; p=0.307). Conclusions Results from the I-CARE trial showed that a nurse-coordinated ACS and depression IC intervention did not reduce depression or improve clinical outcomes among patients with ACS compared to usual care controls. The low prevalence of depression was unexpected and may have minimized the potential added benefits of the IC intervention on depression and clinical outcomes compared to UC. Acknowledgement/Funding This study is supported by a grant from the National Institute of Mental Health (R01MH100332).


Sign in / Sign up

Export Citation Format

Share Document